| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000024366 |
| Receipt No. | R000027937 |
| Scientific Title | Differences of skeletal muscle after reduction of weight in the patients with obesity between internal and surgical treatment |
| Date of disclosure of the study information | 2016/10/15 |
| Last modified on | 2021/08/19 (Ver. 3) |
| Basic information | ||
| Public title | Differences of skeletal muscle after reduction of weight in the patients with obesity between internal and surgical treatment | |
| Acronym | Skeletal muscle in the patients with obesity between internal and surgical treatment
|
|
| Scientific Title | Differences of skeletal muscle after reduction of weight in the patients with obesity between internal and surgical treatment | |
| Scientific Title:Acronym | Skeletal muscle in the patients with obesity between internal and surgical treatment
|
|
| Region |
|
|
| Condition | |||
| Condition | Obesity | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the result of surgical treatment with obesity patients at health science center. Comparison of the change of muscle mass between internal and surgical treatment with obesity patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Comparison of skeletal muscle changes between internal and surgical treatment |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Outpatients at the Kansai Medical University from April 2013 to March 2018. And include following
1.Patients who is more than 20 years old obtaining informed consent. 2.Patients who participate the internal treatment or surgical treatment for a certain period. 3.Independent living . 4.Participants with sufficient understanding and informed consent for this study. |
|||
| Key exclusion criteria | 1.Patients with serious heart failure,arrhythmia,respiratory failure,metabolic diseases.
2.Patients who has underlying disease which is serious,untreated and insufficient treatment. 3.Psychiatric patients who is difficult to participate in this study. 4.Patients whom principal investigators and the research supervisor. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kansai Medical University Hospital | ||||||
| Division name | Health Science | ||||||
| Zip code | |||||||
| Address | 2-3-1 Shinmachi Hirakata city Osaka Japan | ||||||
| TEL | 0728040101 | ||||||
| kimuray@hirakata.kmu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kansai Medical University | ||||||
| Division name | Health Science | ||||||
| Zip code | |||||||
| Address | 2-5-1 Shinmachi Hirakata city Osaka Japan | ||||||
| TEL | 0728040101 | ||||||
| Homepage URL | |||||||
| tsutsumi@hirakata.kmu.ac.jp | |||||||
| Sponsor | |
| Institute | Kansai Medecal University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nothing |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Prospective observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027937 |